These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17653382)

  • 1. An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir.
    Bromfield KM; Gradén H; Hagberg DP; Olsson T; Kann N
    Chem Commun (Camb); 2007 Aug; (30):3183-5. PubMed ID: 17653382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical and azide-free synthetic approach to oseltamivir from diethyl D-tartrate.
    Weng J; Li YB; Wang RB; Li FQ; Liu C; Chan AS; Lu G
    J Org Chem; 2010 May; 75(9):3125-8. PubMed ID: 20394411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 4. A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid.
    Yeung YY; Hong S; Corey EJ
    J Am Chem Soc; 2006 May; 128(19):6310-1. PubMed ID: 16683783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
    Stanley M; Martin SR; Birge M; Carbain B; Streicher H
    Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
    Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
    J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
    [No Abstract]   [Full Text] [Related]  

  • 7. Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor.
    Gong J; Xu W
    Curr Med Chem; 2008; 15(30):3145-59. PubMed ID: 19075659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of
    Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
    Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW
    Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
    Mohan S; McAtamney S; Haselhorst T; von Itzstein M; Pinto BM
    J Med Chem; 2010 Oct; 53(20):7377-91. PubMed ID: 20873795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].
    Ruf BR; Sandow P; Lehmann P; Del Piero L; Skopnik H
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1259-64. PubMed ID: 18509804
    [No Abstract]   [Full Text] [Related]  

  • 12. [How safe was oseltamivir care in the flu pandemic?].
    Holzgrabe U
    Pharm Unserer Zeit; 2011 Mar; 40(2):151-4. PubMed ID: 21630542
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
    Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetry-based design for the chemoenzymatic synthesis of oseltamivir (Tamiflu) from ethyl benzoate.
    Sullivan B; Carrera I; Drouin M; Hudlicky T
    Angew Chem Int Ed Engl; 2009; 48(23):4229-31. PubMed ID: 19425033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-yielding synthesis of the anti-influenza neuraminidase inhibitor (-)-oseltamivir by two "one-pot" sequences.
    Ishikawa H; Suzuki T; Orita H; Uchimaru T; Hayashi Y
    Chemistry; 2010 Nov; 16(42):12616-26. PubMed ID: 20859964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir.
    Carbain B; Collins PJ; Callum L; Martin SR; Hay AJ; McCauley J; Streicher H
    ChemMedChem; 2009 Mar; 4(3):335-7. PubMed ID: 19156651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
    Nitsch-Osuch A; Brydak LB; Wardyn AK
    Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
    Yamashita M
    Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.